Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)

NCT00249873 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

7554

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation
Vascular Risk

Interventions

DRUG: clopidogrel (SR25990C)
DRUG: placebo

Sponsor

Sanofi

Collaborators

[object Object]